substitution for "narrow therapeutic index" (NTI) drugs
December 1997
The new generic warfarin is raising a big controversy about substitution for "narrow therapeutic index" (NTI) drugs.
It's true some drugs have a narrow range between doses that are subtherapeutic...and doses that are toxic. Warfarin is one.
There are others...carbamazepine...digoxin...levothyroxine...phenytoin...theophylline.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote